Nyumbani › Colitis ya Ulcerative › Missouri
Majaribio ya kliniki ya Colitis ya Ulcerative katika jimbo la Missouri
Masomo 16 ya Colitis ya Ulcerative yanatafuta washiriki katika vituo vya jimbo la Missouri.
Miji katika jimbo la Missouri
Maandishi rasmi ya utafiti (Kiingereza)
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
- BVL Research - Kansas ( Site 0292), Liberty
InaajiriHatua 3
Umri wote · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT06651281Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Specialists In Gastroenterology /ID# 283939, St Louis
InaajiriHatua 2
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT07697456A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- SSM Health Medical Group, Bridgeton
- GI Associates Research, LLC, Columbia
- Mid America Gastro Intestinal Consultants, Kansas City
- na zaidi ya 1
InaajiriHatua 4
Umri 18 hadi 80 · Jinsia zote · Imesasishwa 30 Sep 2026 · NCT06581328A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
- Site US-006, St Louis
InaajiriHatua 2
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 29 Sep 2026 · NCT07845487A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)
- BVL Research - Kansas ( Site 1054), Liberty
InaajiriHatua 2
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 28 Sep 2026 · NCT07463183A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
- Washington University, St Louis
InaajiriHatua 2/3
Umri 2 hadi 17 · Jinsia zote · Imesasishwa 24 Sep 2026 · NCT05076175Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Washington University School of Medicine, St Louis
InaajiriHatua 3
Umri 18 hadi 70 · Jinsia zote · Imesasishwa 24 Sep 2026 · NCT06937086Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
- Siteman Cancer Center at West County Hospital, Creve Coeur
- University Health Truman Medical Center, Kansas City
- na zaidi ya 6
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 23 Sep 2026 · NCT03816345A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
- KAD Clinical Research, St Louis
InaajiriHatua 2
Umri 18 hadi 80 · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07483073A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- Washington University School of Medicine, St Louis
InaajiriHatua 3
Umri 2 hadi 19 · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT04844606LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
- KAD Clinical Research, St Louis
- Specialists in Gastroenterology, St Louis
InaajiriHatua 2
Umri 18 hadi 80 · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07415044A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
- Mid-America Gastro-Intestinal Consultants, Kansas City
- BVL Clinical Research, Liberty
- Washington University School of Medicine, St Louis
InaajiriHatua 4
Umri 18 hadi 65 · Jinsia zote · Imesasishwa 21 Sep 2026 · NCT06095128A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Gateway Gastroenterology - Site Number: 8400097, Chesterfield
- BVL Clinical Research - Site Number: 8400005, Liberty
InaajiriHatua 3
Umri 16 hadi 80 · Jinsia zote · Imesasishwa 15 Sep 2026 · NCT07185009An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Gateway Gastroenterology - Site Number: 8400097, Chesterfield
- BVL Clinical Research - Site Number: 8400005, Liberty
InaajiriHatua 3
Umri 16 hadi 80 · Jinsia zote · Imesasishwa 20 Ago 2026 · NCT07184996BOOM-IBD2 Pivotal Clinical Trial
- Gateway GI Research (Objective Health), St Louis
Inaajiri
Umri 18 hadi 85 · Jinsia zote · Imesasishwa 6 Ago 2026 · NCT06571669A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Bridgeton
- Mirador Therapeutics Selected Site, Kansas City
- Mirador Therapeutics Selected Site, Liberty
InaajiriHatua 2
Umri 18 hadi 80 · Jinsia zote · Imesasishwa 12 Mac 2026 · NCT07113522Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.